HTA239 Multicriteria Health Technology Assessments for High-Cost Oncology Drugs in Peru: A Cross-Sectional Study of RENETSA Records 2023-2024
Abstract
Authors
Karina Mayra Aliaga Llerena Jazmin Figueroa Raul Mantilla Luis Mas Victor Castro Oliden